Recent advances on the role of long non-coding RNA H19 in regulating mammalian muscle growth and development
Received date: 2017-05-27
Revised date: 2017-11-03
Online published: 2017-12-20
Supported by
the National Natural Science Foundation of China(31672402);the Science and Technology Program of Sichuan Province(2016NYZ0045)
As one of the first identified long non-coding RNAs (lncRNAs), H19 plays a wide range of roles in vivo, including not only as a tumor suppressor and oncogene involved in disease process, but also as a regulator of growth and development of multiple tissues in mammalian embryos. The function of H19 in muscles (both skeletal and cardiac muscle) draws widespread attention due to the following two reasons. On one hand, H19 promotes myogenic differentiation and myogenesis of skeletal muscle satellite cells (SMSCs) via regulating Igf2 in cis. On the other hand, H19 also modulates the target genes in trans, including sponging let-7, miR-106 or miR-29 to mediate myocyte glucose uptake, cardiomyocyte proliferation and tendon repair, as well as promote embryonic development and muscle regeneration through binding to MBD1 as a chromatin modifier. In this review, we summarize the role of H19 in mammalian muscles, which will provide a reference for further research to unveil the molecular mechanism of muscle growth and development.
Key words： H19; lncRNA; muscle; cis-acting regulation; trans-acting regulation
Chenyu Qin, He Cai, Hanrui Qing, Li, Hongping Zhang . Recent advances on the role of long non-coding RNA H19 in regulating mammalian muscle growth and development[J]. Hereditas(Beijing), 2017 , 39(12) : 1150 -1157 . DOI: 10.16288/j.yczz.17-193
| [1] | Freeman M, Gurdon JB. Regulatory principles of developmental signaling. Annu Rev Cell Dev Biol, 2002, 18: 515-539. |
| [2] | Kelc R, Trapecar M, Gradisnik L, Rupnik MS, Vogrin M. Platelet-rich plasma, especially when combined with a TGF-β inhibitor promotes proliferation, viability and myogenic differentiation of myoblasts. in vitro. PLoS One, 2015, 10(2): e0117302. |
| [3] | Cabianca DS, Casa V, Bodega B, Xynos A, Ginelli E, Tanaka Y, Gabellini D. A long ncRNA links copy number variation to a polycomb/trithorax epigenetic switch in FSHD muscular dystrophy. Cell, 2012, 149(4): 819-831. |
| [4] | Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell, 2011, 147(4): 358-369. |
| [5] | Lu LN, Sun K, Chen XN, Zhao Y, Wang LJ, Zhou L, Sun H, Wang HT. Genome-wide survey by ChIP-seq reveals YY1 regulation of lincRNAs in skeletal myogenesis. EMBO J, 2013, 32(19): 2575-2588. |
| [6] | Mueller AC, Cichewicz MA, Dey BK, Layer R, Reon BJ, Gagan JR, Dutta A. MUNC, a long noncoding RNA that facilitates the function of MyoD in skeletal myogenesis. Mol Cell Biol, 2015, 35(3): 498-513. |
| [7] | Thorvaldsen JL, Duran KL, Bartolomei MS. Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2. Genes Dev, 1998, 12(23): 3693-3702. |
| [8] | Pachnis V, Belayew A, Tilghman SM. Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci USA, 1984, 81(17): 5523-5527. |
| [9] | Brannan CI, Dees EC, Ingram RS, Tilghman SM. The product of the H19 gene may function as an RNA. Mol Cell Biol, 1990, 10(1): 28-36. |
| [10] | Rachmilewitz J, Goshen R, Ariel I, Schneider T, De Groot N, Hochberg A. Parental imprinting of the human H19 gene. FEBS Lett, 1992, 309(1): 25-28. |
| [11] | Ripoche MA, Kress C, Poirier F, Dandolo L. Deletion of the H19 transcription unit reveals the existence of a putative imprinting control element. Genes Dev, 1997, 11(12): 1596-1604. |
| [12] | Maher ER, Reik W. Beckwith-Wiedemann syndrome: imprinting in clusters revisited. J Clin Invest, 2000, 105(3): 247-252. |
| [13] | Demars J, Shmela ME, Rossignol S, Okabe J, Netchine I, Azzi S, Cabrol S, Le Caignec C, David A, Le Bouc Y, El-Osta Y, Gicquel C. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet, 2010, 19(5): 803-814. |
| [14] |